Envista Holdings Corporation
NVST Healthcare Medical Instruments & Supplies
Envista Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 8.32% from fiscal 2024.
- Revenue
- +3.22%
- EPS
- +1,855.6%
- Free cash flow
- −6.48%
- Total debt
- −1.13%
Quarter to September 2026, against a year earlier
Follow NVST
Alert me
Envista Holdings Corporation (NVST) P/E ratio
As of 5 November 2026, Envista Holdings Corporation (NVST) trades at a P/E ratio of 6.4×. Over the past ten years it has ranged from 0.0× (June 2025) to 249× (December 2025); the current reading is higher than 26% of that period. That is below the Medical Instruments & Supplies industry median of 30.3× and below the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 77.5× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 22.8× | 7.23% |
| FY2021 | 21.3× | (87.40%) |
| FY2020 | 169× | 814.43% |
| FY2019 | 18.4× | 233.89% |
| FY2018 | 5.5× | 0.00% |
| FY2017 | 5.5× | 0.00% |
| FY2016 | 5.5× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 6.0× | (86.63%) |
| Jun 2026 | 44.7× | (26.06%) |
| Mar 2026 | 60.4× | (22.09%) |
| Dec 2025 | 77.5× | (65.74%) |
| 28 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| PLSE Pulse Biosciences, Inc compare | n/m |
| MMED MiniMed Group, Inc. compare | n/m |
| TFX Teleflex Incorporated compare | n/m |
| NVST Envista Holdings Corporation | 6.4× |
| STVN Stevanato Group S.p.A. compare | 22.4× |
| MMSI Merit Medical Systems, Inc. compare | 33.2× |
| ICUI ICU Medical, Inc. compare | 69.3× |
| ATRC AtriCure, Inc. compare | 199× |
| WRBY Warby Parker Inc. compare | 434× |
| Medical Instruments & Supplies industry median | 30.3× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on NVST
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement